V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20197185 | 20152662 | 1.7 | 94.2 | Adjuvant (A) | 2019-04-20 | 2019-05-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100209088 |
| 20197197 | 20152663 | 1.74 | 76.3 | null | 2020-01-18 | 2020-01-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101450114 |
| 20197202 | 20152664 | null | 57.3 | Palliative (P) | 2021-12-23 | 2022-01-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101129536 |
| 20197210 | 20152665 | 1.82 | 81.8 | null | null | 2018-07-27 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101044135 |
| 20197215 | 20152666 | 1.6 | 43.6 | null | 2020-01-21 | 2020-02-18 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101492003 |
| 20197222 | 20152667 | 1.88 | 53.4 | Neo-adjuvant (N) | 2017-12-19 | 2017-12-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100988547 |
| 20197230 | 20152668 | 1.84 | 73 | Curative (C) | 2019-04-17 | 2019-04-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101197492 |
| 20197234 | 20152669 | 1.9 | 92 | null | 2019-12-22 | 2020-01-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100693828 |
| 20197248 | 20152670 | 1.69 | 62.4 | Palliative (P) | 2019-03-17 | 2019-03-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100030487 |
| 20197249 | 20152671 | 1.63 | 45.2 | Palliative (P) | 2016-10-16 | 2016-10-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100207563 |
| 20197254 | 20152672 | 1.88 | 60.6 | Palliative (P) | 2021-01-18 | 2021-01-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100092533 |
| 20197258 | 20152673 | 1.9 | 50.2 | null | 2019-05-13 | 2019-05-13 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101057869 |
| 20197259 | 20152674 | 1.76 | 77.2 | Palliative (P) | 2018-05-04 | 2018-05-10 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 100471982 |
| 20197269 | 20152675 | 1.7 | 62.7 | null | 2020-04-08 | 2020-05-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 100827286 |
| 20197270 | 20152676 | 1.69 | 87.05 | null | 2018-07-19 | 2018-08-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100272970 |
| 20197277 | 20152677 | 1.69 | 42.2 | Adjuvant (A) | 2016-12-06 | 2017-01-01 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101518923 |
| 20197278 | 20152678 | 1.7 | 54.4 | Palliative (P) | 2021-01-30 | 2021-03-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100874418 |
| 20197286 | 20152679 | 1.7 | 103 | Palliative (P) | 2017-06-03 | 2017-06-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101635139 |
| 20197290 | 20152680 | 1.59 | 100 | null | 2019-12-16 | 2019-12-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101703340 |
| 20197292 | 20152681 | 1.67 | 58.4 | Palliative (P) | 2020-01-21 | 2020-02-07 | Docetaxel | 02 | N | DOCETAXEL | 100702342 |
| 20197297 | 20152682 | 1.68 | 84.8 | null | 2020-05-10 | 2020-06-08 | Docetaxel | 02 | null | DOCETAXEL | 101126690 |
| 20197304 | 20152683 | 1.58 | 76 | Palliative (P) | 2018-01-13 | 2018-01-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100984163 |
| 20197307 | 20152684 | 1.6 | 76 | Palliative (P) | 2020-04-28 | 2020-09-11 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 101213669 |
| 20197315 | 20152685 | 1.89 | 55.2 | Palliative (P) | 2018-07-18 | 2018-12-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101773479 |
| 20197318 | 20152686 | 1.67 | 45.8 | null | 2019-03-19 | 2019-03-19 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100359019 |
| 20197319 | 20152687 | 1.63 | 70.3 | Palliative (P) | 2019-06-23 | 2019-07-07 | Docetaxel | 02 | null | DOCETAXEL | 101300435 |
| 20197321 | 20152688 | 1.68 | 88 | null | 2018-09-27 | 2018-10-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101817281 |
| 20197327 | 20152689 | 1.63 | 77 | null | 2021-11-09 | 2021-11-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100434794 |
| 20197336 | 20152690 | 1.67 | 62 | null | 2017-04-24 | 2017-05-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100074300 |
| 20197339 | 20152691 | 1.61 | 58 | Palliative (P) | 2020-04-03 | 2020-04-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100452769 |
| 20197347 | 20152692 | 1.68 | 40.1 | Palliative (P) | 2016-04-07 | 2016-05-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100837951 |
| 20197358 | 20152693 | 1.6 | 56.8 | null | 2018-05-18 | 2018-09-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 101098598 |
| 20197361 | 20152694 | 1.69 | 76.9 | Neo-adjuvant (N) | 2016-04-30 | 2017-05-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100345767 |
| 20197365 | 20152695 | 1.76 | 69.9 | null | 2019-05-10 | 2019-05-23 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101199940 |
| 20197367 | 20152696 | 1.63 | 65.4 | Palliative (P) | 2018-01-26 | 2018-01-29 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100845083 |
| 20197370 | 20152697 | 1.69 | 68.8 | Palliative (P) | 2019-09-22 | 2019-09-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101236163 |
| 20197374 | 20152698 | 1.65 | 79 | Palliative (P) | 2015-04-07 | 2016-08-14 | Cetuximab + FOLFIRI cycle 2 onwards | Y | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100855315 |
| 20197378 | 20152699 | 1.74 | 111.2 | Adjuvant (A) | 2017-03-08 | 2017-06-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101724750 |
| 20197380 | 20152700 | 1.59 | 69.4 | null | 2018-09-02 | 2018-09-12 | Docetaxel | 02 | null | DOCETAXEL | 100910123 |
| 20197382 | 20152701 | 1.61 | 99.3 | null | 2019-10-19 | 2020-03-30 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100373944 |
| 20197383 | 20152702 | 1.67 | 81 | null | 2016-12-17 | 2017-09-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101007684 |
| 20197389 | 20152703 | 1.61 | 67.8 | Palliative (P) | 2017-10-25 | 2017-11-11 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101678515 |
| 20197395 | 20152704 | 1.6 | 83 | null | 2018-01-11 | 2018-06-16 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100308873 |
| 20197402 | 20152705 | 1.67 | 52.8 | Palliative (P) | 2021-10-28 | 2021-11-01 | Docetaxel | 02 | N | DOCETAXEL | 101116517 |
| 20197404 | 20152706 | 1.6 | 74.4 | null | 2019-07-13 | 2019-07-21 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100246878 |
| 20197405 | 20152707 | 1.54 | 45.8 | Palliative (P) | 2019-01-30 | 2019-02-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100048381 |
| 20197418 | 20152708 | 1.76 | 55.5 | Adjuvant (A) | 2017-11-21 | 2017-12-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100056065 |
| 20197422 | 20152709 | 1.54 | 67.2 | 03 | 2016-04-05 | 2016-04-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101526633 |
| 20197426 | 20152710 | 0 | 51.9 | null | 2019-10-28 | 2019-12-15 | CETUXIMAB + IRINOTECAN + MDG | N | null | DOCETAXEL | 101048415 |
| 20197428 | 20152711 | 1.76 | 63.05 | null | 2016-04-27 | 2016-05-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100909719 |